Latest Infectious Disease News
Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11
posted April 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Will Ask FDA to Approve Its COVID Vaccine for Kids Under 5
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
posted April 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
White House Moves to Make COVID-19 Antiviral Pills More Widely Available
posted April 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Continuation of Remdesivir Trial Looks at the Drug Paired With Anti-Inflammatory
Short-Term Exposure to Air Pollution Tied to SARS-CoV-2 Infection
posted April 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate 
Air Pollution Tied to Higher Risk for Suicide 
Higher Short-Term Exposure to Pollen Linked to Lower FEV1 in COPD 
Study Reveals Silicosis Rates Among Workers Fabricating Stone Countertops Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
About 1 in 20 Hospitalized U.S. Adults With Firearm Injuries Develop Bacterial Infections Infectious Disease Conference Highlights
Infectious Disease Monthly Briefings
Infectious Disease Conference News
Stay Connected
